期刊文献+

大黄对糖尿病大鼠血管病变保护机制的实验研究 被引量:14

Vascular Protective Effects of Da Huang in Diabetes Mellitus Rats
下载PDF
导出
摘要 目的:探讨大黄对糖尿病血管病变的保护机制。方法:制备糖尿病大鼠模型,并给予大黄干预,8周后,取血测定一氧化氮(NO)及内皮素-1(ET-1)。取胸主动脉环观察不同累积浓度的乙酰胆碱(Ach)对去甲肾上腺素(NE)引起的血管收缩的抑制率。另留取一段胸主动脉制备病理切片,SP法免疫组化染色,观察细胞间黏附分子-1(ICAM-1)及血管细胞间黏附分子-1(VCAM-1)的阳性表达。结果:大黄组与模型组相比能明显抑制升高的血浆ET-1(P<0.05);升高NO的水平(P<0.05);但均达不到正常组的水平(P<0.05)。模型组血管环对NE的收缩反应明显强于正常对照组及大黄组(P<0.05),且大黄组对NE的收缩反应亦强于正常对照组(P<0.05)。在相同Ach浓度下,模型组及大黄组胸主动脉环对Ach的舒张作用明显弱于正常组(P<0.05),而大黄组强于模型组(P<0.05)。大黄组能明显抑制糖尿病大鼠胸主动脉ICAM-1及VCAM-1表达(P<0.05)。结论:大黄具有降低大鼠ET-1及升高NO的作用,能够保护糖尿病大鼠内皮依赖的血管舒张功能,且能够抑制ICAM-1及VCAM-1的表达,具有抗动脉硬化作用。 Objective:To explore the protective mechanism of Chinese Herb-Da Huang on the vascular disease in diabetes mellitus (DM) rats. Methods: The DM rat model was made. Da Huang was given to treatment group. 8 weeks later,blood sample was taken to test nitric oxide(NO) and endothelin-1(ET-1 ).Thoracic aortic rings to observe the ratio of different concentration of Ach inhibite constraction caused by NE. Took down another part of aorta to make pathology slice,method of SP immunohistochemistry staining, observed the expression of ICAM-1 and VCAM-1. Result: Da Huang group obviously decreased plasma ET-1 and increased the level of NO comparied with Diabetes group (P 〈 0.05), but could not reach the level of the normal control group (P 〈 0.05). The expression of ICAM-1 and VCAM-1 could be obviously inhibited in Da Huang group comparied with diabetes contrast group. But obviously stronger than normal control group (P 〈 0.05). Conclusion: Chinses medicine Da Huang could decrease the level of ET-1 and increase the level of NO in diabetes rats, they have the function of protect the endothelium of vessel, and could inhibte the expression of ICAM-1 and VCAM-1, act as the role of anti-atherosclerosis.
出处 《中国实验方剂学杂志》 CAS 2008年第2期63-66,共4页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 大黄 糖尿病 胸主动脉 内皮 Da Huang diabetes thoracic aorta endothelium
  • 相关文献

参考文献11

  • 1Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature, 1993,62(29) :801.
  • 2Ross R. Atherosclerosis-an inflammation disease[ J]. N Engl J Med, 1999,340(2) : 115-126.
  • 3Fang L, Wei H, Mak KH, et al. Marker of low-grade inflammation and soluble cell adhension molecules in Chinese patients with coronary artery disase [ J ]. Cardiol, 2004,20(14):1433-1438.
  • 4张均田.现代药理实验方法学[M].北京:北京医科大学中国协和医科大学联合出版社,1998.
  • 5于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 6龙超良,汪海,肖文彬.吡那地尔抗高血压治疗后血管对扩血管药物反应性的变化[J].中国药理学通报,1997,13(4):308-311. 被引量:4
  • 7Cormier J, Cormier F, Fichelle J. Arterial disease of the lower limbs in diabetic patients [ J ]. Rev Prat, 1995,45 ( 1 ) : 50.
  • 8Porta M, Selba ML, Molinatti P, et al. Endothelial cell function in diabetic microangiopathy [ J ]. Diabetalogia, 1992, (5):161.
  • 9Zhu BH, Guan YY. Contractile responses of diabetic rat aorta to phenylephrine at different stage of diabetic duration[J]. Acta Pharmacol Sin,2001,22(5) :445-449.
  • 10李慧,邹大进.2型糖尿病及肥胖与慢性炎症因子[J].第二军医大学学报,2003,24(11):1244-1246. 被引量:38

二级参考文献25

  • 1Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly[J]. Diabetes,2001,50(10):2384-2389.
  • 2Freeman DJ, Norrie J, Caslake MJ,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[J].Diabetes,2002,51(5) :1596-1600.
  • 3Festa A, D'Agostino R Jr, Howard G,et al. Chronic subclinical inflammation as part of the insulin resistance sydrome. The Insulin Resistance Atherosclerosis Study (IRAS) [J]. Circulation,2000,102(1) :42-47.
  • 4Frohlich M,Imhof A,Berg G,et al. Association between C-reactive protein and features of the metabolic syndrome:a population-based study [J]. Diabetes Care, 2000, 23 ( 12 ) : 1835-1839.
  • 5Visser M, Bouter LM, Geraldine MM, et al. Elevated C-reactive protein levels in overweight and obese adults[J], JAMA,1999,282(22) :2131-2135.
  • 6Calandra T, Bernhagen J, Mitchell RA,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor[J], J Exp Med, 1994,179(6) :1895-1902.
  • 7Pickup JC,Mattock MB,Chusney GD,et al. NIDDM as a disease of the innate immune system: association of acute phase reaction and interleukin-6 with metabolic syndrome X[J].Diabetologia, 1997,40( 11 ) : 1286-1292.
  • 8Hrnciar J,Gabor D, Hrnciarova M, et al. Relation between cytokines(TNF-a,IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[J].Vnitr Lek, 1999,45(1) : 11-16.
  • 9Uysal KT, Wlesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-a function[J]. Nature,1997,389(6651) :610-614.
  • 10Hotamisligil GS,Shargill NS,Spiegelman BM. Adipose expression of TNF-a:Direct role in obesity-linked insulin resistance[J]. Science, 1993,259(5091 ) :87-91.

共引文献493

同被引文献202

引证文献14

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部